Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Outset Medical (OM) EBITDA Margin (2019 - 2025)

Historic EBITDA Margin for Outset Medical (OM) over the last 7 years, with Q4 2025 value amounting to 61.05%.

  • Outset Medical's EBITDA Margin rose 131300.0% to 61.05% in Q4 2025 from the same period last year, while for Dec 2025 it was 55.83%, marking a year-over-year increase of 438900.0%. This contributed to the annual value of 55.83% for FY2025, which is 438900.0% up from last year.
  • Per Outset Medical's latest filing, its EBITDA Margin stood at 61.05% for Q4 2025, which was up 131300.0% from 53.73% recorded in Q3 2025.
  • Outset Medical's EBITDA Margin's 5-year high stood at 53.68% during Q2 2025, with a 5-year trough of 174.49% in Q2 2022.
  • For the 5-year period, Outset Medical's EBITDA Margin averaged around 111.03%, with its median value being 120.02% (2022).
  • In the last 5 years, Outset Medical's EBITDA Margin surged by 1816000bps in 2021 and then crashed by -558900bps in 2022.
  • Quarter analysis of 5 years shows Outset Medical's EBITDA Margin stood at 144.92% in 2021, then increased by 14bps to 124.42% in 2022, then increased by 2bps to 122.44% in 2023, then skyrocketed by 39bps to 74.18% in 2024, then rose by 18bps to 61.05% in 2025.
  • Its EBITDA Margin stands at 61.05% for Q4 2025, versus 53.73% for Q3 2025 and 53.68% for Q2 2025.